From: A quantitative atlas of histone modification signatures from human cancer cells
Cell line | Media | Comment |
---|---|---|
1. 293 | DMEM | Embryonic kidney |
2. A549 | DMEM | Adenocarcinomic alveolar basal epithelial |
3. C33a | DMEM | Cervical carcinoma |
4. DUT145 | DMEM | Prostate cancer |
5. H1229 | RPMI | Lung carcinoma |
6. HaCAT | RPMI | Immortalized, non-tumorigenic keratinocyte |
7. HCT116 | McCoy 5A | Colorectal carcinoma |
8. HeLa | Joklik | Cervical carcinoma |
9. hESC2 | DMEM | Human embryonic stem cells |
10. HFF | DMEM | Human foreskin fibroblasts |
11. HL60 | IMM | Promyelocytic leukemia cells |
13. Huh7.0 | DMEM | Hepatocarcinoma |
14. Huh7.5 | DMEM | Hepatocarcinoma (RIG-I-deficient) |
14. MCF7 | DMEM | Breast carcinoma |
15. MDaMB231 | L15 | Breast carcinoma |
16. Mdm13 | DMEM | Monocyte-derived macrophages |
17. NB4 | RPMI | Acute promyelocytic cell line |
18. PANC1 | DMEM | Pancreatic carcinoma, epithelial-like |
19. PC3 | DMEM | Prostate cancer |
20. SAOS | McCoy 5A | Epithelial-like osteosarcoma cell line |
21. SW480 | L15 | Colon adenocarcinoma |
22. U2OS | DMEM | Osteosarcoma |
23. U251 | DMEM | Glioblastoma |
24. U937 | RPMI | Leukemic monocyte lymphoma |